Effect of alpha-tocopherol and beta-carotene supplementation on macrovascular complications and total mortality from diabetes: Results of the ATBC Study

Annals of Medicine

Volumn 42, Issue 3, 2010, Pages 178-186

  Kataja Tuomola, Merja K ^a   Kontto, Jukka P ^a   Männistö, Satu ^a   Albanes, Demetrius ^b   Virtamo, Jarmo R ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Antioxidants; Cohort studies; Complications; Diabetes; Epidemiology; Mortality

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE;

ADULT; AGED; ARTICLE; CANCER PREVENTION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; FACTORIAL DESIGN; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SMOKING; SUPPLEMENTATION; TREATMENT OUTCOME;

AGED; ALPHA-TOCOPHEROL; BETA CAROTENE; CORONARY DISEASE; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DOUBLE-BLIND METHOD; FINLAND; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; SMOKING; STROKE; SURVIVAL RATE; TREATMENT OUTCOME; VITAMINS;

EID: 77950789625     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890903508887     Document Type: Article

References (23)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-1053 (Pubitemid 38579764)
2. Juutilainen A, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Type 2 diabetes as a 'coronary heart disease equivalent': an 18-year prospective population-based study in Finnish subjects. Diabetes Care. 2005;28:2901-2907 (Pubitemid 43942922)
3. Folsom AR, Rasmussen ML, Chambless LE, Howard G, Cooper LS, Schmidt MI, et al. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. Diabetes Care. 1999;22:1077-1083 (Pubitemid 29293959)
4. Chertow B. Advances in diabetes for the millennium: vitamins and oxidant stress in diabetes and its complications. MedGenMed. 2004;6 Suppl 3:S4. (Pubitemid 41529198)
5. Pennathur S, Heinecke JW. Mechanisms for oxidative stress in diabetic cardiovascular disease. Antioxid Redox Signal. 2007;9:955-969 (Pubitemid 46919596)
6. Jay D, Hitomi H, Griendling KK. Oxidative stress and diabetic cardiovascular complications. Free Radic Biol Med. 2006;40:183-192 (Pubitemid 43069343)
7. Carr AC, Zhu BZ, Frei B. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). Circ Res. 2000;87:349-354
8. Tsuchihashi H, Kigoshi M, Iwatsuki M, Niki E. Action of beta-carotene as an antioxidant against lipid peroxidation. Arch Biochem Biophys. 1995;323:137-147
9. Lonn E, Yusuf S, Hoogwerf B, Poque J, Yi Q, Zinman B, et al. Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. Diabetes Care. 2002;25:1919-1927 (Pubitemid 41071045)
10. Sacco M, Pellegrini F, Roncaglioni MC, Avanzini FM, Tognoni G, Nicolucci A. Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes Care. 2003;26:3264-3272 (Pubitemid 37466885)
11. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebocontrolled trial. Lancet. 2002;360:23-33. (Pubitemid 34756488)
12. Cook NR, Albert CM, Gaziano JM, Zaharris E, MacFayden J, Danielson E, et al. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med. 2007;167:1610-1618 (Pubitemid 47280341)
13. Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA. 2005;294:56-65. (Pubitemid 41002839)
14. Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFayden J, et al. Vitamins E and C in the Prevention of Cardiovascular Disease in Men, The Physicians' Health Study II Randomized Controlled Trial. JAMA. 2008;300: 2123-2133
15. The Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study: design, methods, participant characteristics and compliance. The ATBC Cancer Prevention Study Group. Ann Epidemiol. 1994;4:1-10. (Pubitemid 24102333)
16. Rapola JM, Virtamo J, Korhonen P, Haapakoski J, Hartman AM, Edwards BK, et al. Validity of diagnoses of major coronary events in national registers of hospital diagnoses and deaths in Finland. Eur J Epidemiol. 1997;13:133-138 (Pubitemid 27100196)
17. Leppala JM, Virtamo J, Heinonen OP. Validation of stroke diagnosis in the National Hospital Discharge Register and the Register of Causes of Death in Finland. Eur J Epidemiol. 1999;15:155-160 (Pubitemid 29124806)
18. Grambsch P, Therneau T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81: 515-526
19. Levy AP, Gerstein HC, Miller-Lotan R, Ratner R, McQueen M, Lonn E, et al. The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes. Diabetes Care. 2004;27:2767. (Pubitemid 39441487)
20. Milman U, Blum S, Shapira C, Aronson D, Miller-Lotan R, Anbinder Y, et al. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype. A prospective double-blinded clinical trial. Arterioscler Thromb Vasc Biol. 2008;28:341-7. (Pubitemid 351161209)
21. Albanes A, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rautalahti M, et al. Tocopherol and carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: Effects of base-line characteristics and study compliance. J Natl Cancer Inst. 1996;88:1560-1570 (Pubitemid 26374509)
22. Omenn GS, Goodmann GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Effi cacy Trial. J Natl Cancer Inst. 1996;88:1550-1559 (Pubitemid 26374508)
23. Dietary Reference Intake. A Report of the Panel on Micronutrients, Subcommittees on Upper Reference Levels of Nutrients and of Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientifi c Evaluation of Dietary Reference Intakes. Washington, DC: National Academy Press; 2001.